Addition to Moberg Pharma´s management team
STOCKHOLM, September 22nd 2017, Moberg Pharma AB (OMX: MOB) appoints Torbjörn Wärnheim, Director Pharmaceutical Innovation and Development, as a member of Moberg’s Management Team, effective from today. Torbjörn Wärnheim has had this position at Moberg Pharma since 2013.Prior to his position with Moberg, Torbjörn Wärnheim was Vice President R&D at Fresenius Kabi. In addition to this he has held senior level positions at ACO HUD and Pharmacia & Upjohn among others. Torbjörn Wärnheim has a broad experience of pharmaceutical development of Rx- and OTC-products, and is associate professor at